The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Loryna 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
Patients are struggling to fill Loryna 28 Day prescriptions in 2026. Here's what providers need to know about availability, substitution, and clinical guidance.
Methotrexate Shortage: What Providers and Prescribers Need to Know in 2026
The methotrexate injection shortage persists in 2026. Here is what rheumatologists, oncologists, and PCPs need to know about availability and alternatives.
Mycophenolate Mofetil Shortage: What Providers and Prescribers Need to Know in 2026
The mycophenolate mofetil shortage creates real clinical challenges for transplant teams and rheumatologists. Here's what prescribers need to know and do in 2026.
Nextstellis 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for OB/GYNs, PCPs, and NPs on Nextstellis availability challenges in 2026, including prescribing workarounds, alternatives, and patient communication strategies.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Nivestym Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for oncologists and prescribers on Nivestym (filgrastim-aafi) availability challenges in 2026, including biosimilar alternatives, formulary navigation, and patient support resources.
Norgestrel Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for OB/GYNs, PCPs, and NPs: norgestrel (Opill) availability in 2026, patient access barriers, and prescribing alternatives when needed.
Nuedexta Shortage: What Providers and Prescribers Need to Know in 2026
While Nuedexta is not on the FDA shortage list, prescribers are seeing real access barriers. Here's what providers need to know about availability, PA, and patient support in 2026.
Spinraza (Nusinersen) Access Update: What Providers and Prescribers Need to Know in 2026
The FDA approved a high-dose Spinraza regimen in March 2026, new gene therapies have entered the market, and insurer policies are evolving. Here's what SMA prescribers need to know.
Ogsiveo Shortage: What Providers and Prescribers Need to Know in 2026
Ogsiveo is not in FDA shortage, but access issues, prior auth burdens, and the 2025 tablet change are causing real disruptions. Key facts for prescribers.
Olmesartan Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on olmesartan availability in 2026: supply landscape, formulary considerations, switching strategies, and how to protect your patients.
Oxandrolone Withdrawal: What Providers and Prescribers Need to Know in 2026
The FDA withdrew oxandrolone's commercial approval in June 2023. This guide helps providers understand the regulatory change, compounding options, and how to support affected patients.
Pantoprazole Shortage: What Providers and Prescribers Need to Know in 2026
Clinicians prescribing pantoprazole in 2026 need current data on availability, formulary issues, IV supply, and therapeutic substitution guidance.